Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Beck

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Research Square|December 31, 2025
Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2Oskar Schnappauf, Hongying Wang, Qing Zhou, et al.
Blood|March 2, 2026
Inflammatory cell death and monocyte dysfunction in VEXAS syndromePaul Breillat, Samuel J Magaziner, Stéphane M Camus, et al.
Neurogenetics|May 2, 2019
A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activityDavid B Beck, T Subramanian, S Vijayalingam, et al.
The Journal of Experimental Medicine|February 27, 2025
The common HAQ STING allele prevents clinical penetrance of COPA syndromeNoa Simchoni, Shogo Koide, Maryel Likhite, et al.
The EMBO Journal|February 15, 2024
Shared and distinct mechanisms of UBA1 inactivation across different diseasesJason C Collins, Samuel J Magaziner, Maya English, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Shared and Distinct Mechanisms of UBA1 Inactivation Across Different DiseasesJason C Collins, Samuel J Magaziner, Maya English, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
Cell Reports. Medicine|August 16, 2023
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXASZhijie Wu, Shouguo Gao, Qingyan Gao, et al.
Blood Advances|August 24, 2021
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Ifeyinwa Emmanuela Obiorah, Bhavisha A Patel, Emma M Groarke, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Research Square|December 31, 2025
Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2Oskar Schnappauf, Hongying Wang, Qing Zhou, et al.
Blood|March 2, 2026
Inflammatory cell death and monocyte dysfunction in VEXAS syndromePaul Breillat, Samuel J Magaziner, Stéphane M Camus, et al.
Neurogenetics|May 2, 2019
A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activityDavid B Beck, T Subramanian, S Vijayalingam, et al.
The Journal of Experimental Medicine|February 27, 2025
The common HAQ STING allele prevents clinical penetrance of COPA syndromeNoa Simchoni, Shogo Koide, Maryel Likhite, et al.
The EMBO Journal|February 15, 2024
Shared and distinct mechanisms of UBA1 inactivation across different diseasesJason C Collins, Samuel J Magaziner, Maya English, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Shared and Distinct Mechanisms of UBA1 Inactivation Across Different DiseasesJason C Collins, Samuel J Magaziner, Maya English, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
Cell Reports. Medicine|August 16, 2023
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXASZhijie Wu, Shouguo Gao, Qingyan Gao, et al.
Blood Advances|August 24, 2021
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Ifeyinwa Emmanuela Obiorah, Bhavisha A Patel, Emma M Groarke, et al.
Pageof 9